Source link : https://www.newshealth.biz/health-news/b-cell-depleting-drug-shows-benefit-in-igg-related-disease/
WASHINGTON — The B-cell depleting agent inebilizumab (Uplizna) dramatically reduced the risk of flares and increased year-long remission of IgG4-related disease (RD), new research has found. In a phase 3, multicenter, double-blind, randomized, placebo-controlled trial of 135 adults with active IgG4-RD, treatment with inebilizumab resulted in a significant 87% reduction in flare risk and nearly […]
Author : News Health
Publish date : 2024-11-17 16:15:02
Copyright for syndicated content belongs to the linked Source.
inHealth